Latest features in GaBI Journal, 2014, Issue 3
Regional regulatory processes for the approval of biosimilars; differences and similarities
Barriers to market uptake of biosimilars in the US
Ongoing initiatives to improve prescribing efficiency in China; statins as a case history
GnRH agonists and antagonists in prostate cancer
Recommendations for the regulation of biosimilars and their implementation in Latin America
Biosimilars collaboration at Amgen and Actavis
ECCO 2013 survey highlights lack of confidence in biosimilars
Source URL: https://gabi-journal.net/20143-gabi-journal-table-of-contents.html
Copyright ©2024 GaBI Journal unless otherwise noted.